U.S. Markets closed

Quintiles IMS Holdings, Inc. (Q)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
84.70+0.48 (+0.57%)
At close: 4:01PM EDT

84.84 0.14 (0.17%)
After hours: 5:00PM EDT

People also watch
LVLTCIENVODSUNWJNPR

Quintiles IMS Holdings, Inc.

4820 Emperor Boulevard
Durham, NC 27703
United States
919-998-2000
http://www.quintilesims.com

SectorHealthcare
IndustryMedical Laboratories & Research
Full Time Employees50,000

Key Executives

NameTitlePayExercisedAge
Mr. Ari BousbibChairman, Chief Exec. Officer and Pres6.64MN/A56
Dr. Dennis B. Gillings CBE, Ph.D.Founder and Lead DirectorN/AN/A73
Mr. Michael R. McDonnell CPAChief Financial Officer and Exec. VP1.83MN/A53
Mr. James H. Erlinger IIIExec. VP, Gen. Counsel and Sec.908.09kN/A59
Mr. W. Richard Staub IIIPres of R&D Solutions Bus. Unit772.97kN/A54
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Quintiles IMS Holdings, Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order to life science companies, and investment and financial sectors that deal with life science companies; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level to pharmaceutical sales organizations. This segment also provides OneKey, a reference database of healthcare professionals; real-world insights, and various cloud-based applications and related implementation services; and strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services. The Research & Development Solutions segment offers biopharmaceutical development services comprising project management and clinical monitoring, clinical trial support, and strategic planning and design services, as well as clinical trial, genomic, and bioanalytical laboratory services. The Integrated Engagement Services segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. Quintiles IMS Holdings, Inc. serves pharmaceutical, biotechnology, medical device, and healthcare companies. The company was formerly known as Quintiles Transnational Holdings Inc. and changed its name to Quintiles IMS Holdings, Inc. as a result of its merger with IMS Health Holdings, Inc. in October 2016. The company was founded in 1982 and is headquartered in Durham, North Carolina.

Corporate Governance

Quintiles IMS Holdings, Inc.’s ISS Governance QualityScore as of May 1, 2017 is 7. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 9; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.